Capgemini


CAPGEMINI'S STRATEGIC SHIFT TO R&D (ADD, 15% UPSIDE)

11/02/20 -"The narrow success of the tender cash offer of Capgemini (Add, France) on the shares of Altran Technologies did put an end to a long status quo. The stock market welcomed this result considering that ..."

Pages
57
Language
English
Published on
11/02/20
You may also be interested by these reports :
31/10/25
The recent share price decline, mainly linked to the announcement of CEO C. Malargé’s departure (-8.75% following the announcement), adds to already ...

31/10/25
The change in the target price is due to a change in the analyst covering the stock, complemented by the usage of systematic intrinsic and peer-based ...

30/10/25
Q3 2025 was a moderate quarter in terms of organic growth and EBIT margin progression. Conversely, the group reinforced its visibility through strong ...

29/10/25
Sopra Steria keeps investors waiting. The French group finds itself at an impasse for 2025, with no clear return to growth expected before 2026. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO